Showing results (921-930 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|February 22, 2014
The evidence for a beneficial role of vitamin A in multiple sclerosisYara Dadalti Fragoso, Patrick N Stoney, Peter J McCafferyCNS Drugs|January 29, 2017
New Formulations of Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder: Pharmacokinetics, Efficacy, and TolerabilitySamuele Cortese, Giulia D'Acunto, Eric Konofal, et al.CNS Drugs|March 17, 2019
Current and Emerging Treatment Strategies for Neuronal Ceroid LipofuscinosesAlfried Kohlschütter, Angela Schulz, Udo Bartsch, et al.CNS Drugs|April 14, 2017
Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of MigrainePeer Tfelt-Hansen, Frederik Nybye Ågesen, Agniezka Pavbro, et al.CNS Drugs|January 20, 2017
Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician's OverviewMartin J BrodieCNS Drugs|March 23, 2021
Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut SyndromeSimona Lattanzi, Eugen Trinka, Pasquale Striano, et al.CNS Drugs|November 13, 2021
The Impact of Lithium on Brain Function in Bipolar Disorder: An Updated Review of Functional Magnetic Resonance Imaging StudiesEmilio Bergamelli, Lorenzo Del Fabro, Giuseppe Delvecchio, et al.CNS Drugs|October 27, 2012
Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanerceptEdward Tobinick, Nancy M Kim, Gary Reyzin, et al.CNS Drugs|January 11, 2014
A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS studyVirginie Gardette, Maryse Lapeyre-Mestre, Antoine Piau, et al.Pageof 211